Please use this identifier to cite or link to this item:
|Title:||Bradykinin-activated contractile signalling pathways in human myometrial cells are differentially regulated by arrestin proteins.|
|Authors:||Willets, Jonathon Mark|
Brighton, Paul J.
Nash, Craig A.
Konje, Justin Chi
|Citation:||Molecular and Cellular Endocrinology, 2015, 407, pp. 57-66|
|Abstract:||Bradykinin is associated with infections and inflammation, which given the strong correlation between uterine infection and preterm labour may imply that it could play a role in this process. Therefore, we investigated bradykinin signalling, and the roles that arrestin proteins play in their regulation in human myometrial cells. Bradykinin induced rapid, transient intracellular Ca[superscript: 2+] increases that were inhibited following B[subscript: 2] receptor (B[subscript: 2]R) antagonism. Arrestin2 or arrestin3 depletion enhanced and prolonged bradykinin-stimulated Ca[superscript: 2+] responses, and attenuated B[subscript: 2]R desensitisation. Knockdown of either arrestin enhanced B[subscript: 2]R-stimulated ERK1/2 signals. Moreover, depletion of either arrestin elevated peak-phase p38-MAPK signalling, yet only arrestin3 depletion prolonged B[subscript: 2]R-induced p38-MAPK signals. Arrestin2-knockdown augmented bradykinin-induced cell movement. Bradykinin stimulates pro-contractile signalling mechanisms in human myometrial cells and arrestin proteins play key roles in their regulation. Our data suggest bradykinin not only acts as an utertonin, but may also have the potential to enhance the contractile environment of the uterus.|
|Version:||Post-review (final submitted)|
|Rights:||Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.|
|Appears in Collections:||Published Articles, Dept. of Cancer Studies and Molecular Medicine|
Files in This Item:
|MCE-D-14-00412R2 deposit.pdf||Post-review (final submitted)||577.17 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.